Cargando…

Angiogenesis - still a worthwhile target for breast cancer therapy?

Detalles Bibliográficos
Autores principales: Lord, Simon, Harris, Adrian L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005739/
https://www.ncbi.nlm.nih.gov/pubmed/21172081
http://dx.doi.org/10.1186/bcr2748
_version_ 1782194129781915648
author Lord, Simon
Harris, Adrian L
author_facet Lord, Simon
Harris, Adrian L
author_sort Lord, Simon
collection PubMed
description
format Text
id pubmed-3005739
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30057392010-12-21 Angiogenesis - still a worthwhile target for breast cancer therapy? Lord, Simon Harris, Adrian L Breast Cancer Res Short Communication BioMed Central 2010 2010-12-20 /pmc/articles/PMC3005739/ /pubmed/21172081 http://dx.doi.org/10.1186/bcr2748 Text en Copyright ©2010 BioMed Central Ltd.
spellingShingle Short Communication
Lord, Simon
Harris, Adrian L
Angiogenesis - still a worthwhile target for breast cancer therapy?
title Angiogenesis - still a worthwhile target for breast cancer therapy?
title_full Angiogenesis - still a worthwhile target for breast cancer therapy?
title_fullStr Angiogenesis - still a worthwhile target for breast cancer therapy?
title_full_unstemmed Angiogenesis - still a worthwhile target for breast cancer therapy?
title_short Angiogenesis - still a worthwhile target for breast cancer therapy?
title_sort angiogenesis - still a worthwhile target for breast cancer therapy?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005739/
https://www.ncbi.nlm.nih.gov/pubmed/21172081
http://dx.doi.org/10.1186/bcr2748
work_keys_str_mv AT lordsimon angiogenesisstillaworthwhiletargetforbreastcancertherapy
AT harrisadrianl angiogenesisstillaworthwhiletargetforbreastcancertherapy